Insider: Espinoza Octavio Chief Financial Officer - LIGAND PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 21,010 | 0 | 21,010 |
| Value | $4,193,385.90 | $0.00 | $4,193,385.90 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2026 | DDS | 3,057 | Direct | COM | $225.00 | $687,825.00 | 21,010 |
| 03/04/2026 | DDS | 950 | Direct | COM | $201.73 | $191,640.27 | 32,685 |
| 03/04/2026 | DDS | 698 | Direct | COM | $201.09 | $140,363.54 | 33,635 |
| 03/04/2026 | DDS | 53 | Direct | COM | $200.08 | $10,604.12 | 34,333 |
| 03/04/2026 | DDS | 699 | Direct | COM | $198.71 | $138,894.93 | 34,386 |
| 03/04/2026 | DDS | 697 | Direct | COM | $202.79 | $141,342.75 | 31,988 |
| 03/04/2026 | DDS | 743 | Direct | COM | $204.74 | $152,125.46 | 30,577 |
| 03/04/2026 | DDS | 3,413 | Direct | COM | $208.80 | $712,620.75 | 21,662 |
| 03/04/2026 | DDS | 2,457 | Direct | COM | $207.91 | $510,823.08 | 25,075 |
| 03/04/2026 | DDS | 1,588 | Direct | COM | $206.89 | $328,541.96 | 27,532 |
| 03/04/2026 | DDS | 1,457 | Direct | COM | $205.79 | $299,841.42 | 29,120 |
| 03/04/2026 | DDS | 668 | Direct | COM | $203.63 | $136,023.97 | 31,320 |
| 12/12/2025 | DDS | 1,804 | Direct | COM | $188.31 | $339,711.24 | 26,186 |
| 05/09/2025 | AAP | 1,000 | Direct | COM | $103.89 | $103,890.00 | 27,432 |
| 05/09/2025 | AAP | 500 | Direct | COM | $104.40 | $52,200.00 | 27,932 |
| 03/04/2025 | DDS | 5,000 | Direct | COM | $115.03 | $575,148.50 | 18,879 |
| 12/23/2024 | DDS | 2,104 | Direct | COM | $116.37 | $244,850.48 | 20,647 |
| 09/20/2024 | DDS | 275 | Direct | COM | $103.86 | $28,562.19 | 25,410 |
| 09/20/2024 | DDS | 200 | Direct | COM | $103.98 | $20,796.00 | 25,685 |
| 09/20/2024 | DDS | 800 | Direct | COM | $103.95 | $83,160.00 | 24,610 |
| 05/17/2024 | DDS | 5,022 | Direct | COM | $86.67 | $435,232.63 | 23,513 |
| 05/17/2024 | DDS | 134 | Direct | COM | $86.65 | $11,611.06 | 23,379 |
| 05/16/2024 | DDS | 2,264 | Direct | COM | $86.00 | $194,711.70 | 21,618 |
| 05/15/2024 | DDS | 5,873 | Direct | COM | $86.01 | $505,148.48 | 23,882 |
| 02/28/2024 | DDS | 140 | Direct | COM | $88.46 | $12,384.40 | 29,755 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research